Decision aid for surgical management of benign prostatic hyperplasia - Assessing acceptability of the French version

Exploring all surgical interventions for benign prostatic hyperplasia (BPH) can be time-consuming. We developed the first online CUA-endorsed BPH surgical Patient Decision Aid (PtDA), including all guideline-approved surgical modalities. Our study assesses the acceptability of the tool's French version (FRv) among patients and urologists.

A PtDA was developed including 9 surgical modalities: monopolar transurethral resection of the prostate (TURP), bipolar TURP, GreenLight photovaporization, endoscopic enucleation of the prostate, Rezum, Urolift, Aquablation, open retropubic prostatectomy, and robotic simple prostatectomy. Ten urologists who perform BPH surgery and 21 patients with a history of BPH surgery were recruited. Alpha-testing was performed for the FRv and compared to the English version (ENv).

In both versions of the PtDA, the language was considered clear (urologists FRv 78%; ENv 92%, patients FRv 91%; ENv 100%) and outcomes correctly reported (urologists FRv 71%; ENv 82%) and well explained (patients FRv 91%; ENv 90%). Most patients believed the PtDA would have been useful during their consultation (FRv=86%, ENv=89%), and all recommended it for future patients. A higher proportion of patients, versus urologists, found the PtDA of appropriate duration (urologists FRv 46%; ENv 64%, patients FRv 90%; ENv 84%) and length (urologists FRv 54%; ENv 64%, patients FRv 57%; ENv 84%). Urologists mainly recommended text lightening and integrating illustrations.

While the FRv was found to be acceptable, it underperformed the ENv among urologists due to its information overload. The FRv will be rendered more concise to facilitate its integration into clinical practice.

4.